Bruce D. Cheson, PhD

The Center for Cancer and Blood Disorders, American Oncology Partners of Maryland, Bethesda, MD, USA

Poster(s):

• 1512 - Pirtobrutinib after a Covalent BTK Inhibitor in Pretreated Chronic Lymphocytic Leukemia: A Phase 2 Dose Optimization Trial in Progress